Cargando…
FRI063 Effectiveness Of Liraglutide In Treating Obesity And Improving Hepatic Steatosis
Disclosure: A.A. Alfadda: None. A. Masood: None. B.M. Alsuwayni: None. A.M. Alhossan: None. Background: Obesity is a chronic relapsing disease with a multifactorial pathology. Chronic inflammation is an important underlying cause, that is also a reason for development of obesity associated comorbidi...
Autores principales: | Alfadda, Assim Abdulaziz, Masood, Afshan, Alsuwayni, Bashayr M, Alhossan, Abdulaziz M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553479/ http://dx.doi.org/10.1210/jendso/bvad114.073 |
Ejemplares similares
-
FRI046 Clinical Phenotyping Of Adults With Genetic Obesity
por: Welling, Mila Sofie, et al.
Publicado: (2023) -
The Use of Liraglutide in Obese Patients With COVID-19: A Case Report
por: Hanada, Taliê Zanchetta Buani, et al.
Publicado: (2021) -
MON-LB108 Measurement Of Carotid Intima,hepatic Steatosis And Inflammatory Markers In Obese Children
por: Bazan, Maria Cristina
Publicado: (2020) -
FRI032 Cellular Insights Into Metabolically Healthy And Unhealthy Obesity
por: Petersen, Max C, et al.
Publicado: (2023) -
FRI029 Chronic Free Fatty Acid Elevation Is Associated With An Overcompensatory Increase In Hepatic Mitochondrial Function In Patients With Overweight Or Obesity
por: Bril, Fernando, et al.
Publicado: (2023)